EX

Exponent, Inc.

EXPOIndustrialsNASDAQ

Engineering & Construction · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$582.0M
+4.2% YoY
Net Income
$106.0M
-2.7% YoY
EBITDA
$129.9M
+0.5% YoY
Free Cash Flow
$76.9M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ RSI OverboughtRSI 76.5, above 70, stock may be overbought
Oct 19▼ RSI OverboughtRSI 76.2, above 70, stock may be overbought
About Exponent, Inc.

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. At a $3.68B market cap, Exponent, Inc. ranks as a mid-cap company within industrials. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.

Where EXPO stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, EXPO finished 12.71% above its 150-day moving average ($64.10) and 9.60% above its 200-day moving average ($65.92). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is EXPO overbought or oversold?

At the October 20, 2026 close, EXPO's RSI(14) was 76.5, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$3.68B
P/E (TTM)34.72
Fwd P/E28.46
EPS$2.23
Beta0.70
52W Change+14.2%
Dividend Yield1.59%
ROE31.2%
Analysis

Exponent, Inc. carries $80.7M in total debt against $66.6M in cash reserves — debt is modestly above the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $76.9M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 31.2%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 11.3% further supports the picture of efficient asset utilization. Revenue has grown from $466.3M (2021) to $582.0M (2025), reflecting a 25% increase over the period.

With a beta below 0.7, Exponent, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. No single metric tells the full story. Reviewing EXPO's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Industrials stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms